Flextronics Medical helps customers become more competitive by bringing innovative products to market faster and at lower cost through world-class integrated design, manufacturing, distribution and service. Our turnkey services offer medical customers a competitive advantage in a constantly evolving marketplace where speed, innovation and agility are critical.
Our qualified design and manufacturing facilities worldwide have expertise in both low volume/high mix, as well as high volume/low mix product requirements in the following markets: Consumer diagnostics (blood glucose meters, hand-held wireless controllers, hearing aids, aesthetic care devices); drug delivery (electro-mechanical drug delivery systems for insulin, HGH and pain treatment); microelectronics for implantable devices (neuro-stimulation, cochloear implants and cardiac rhythm management); disposable devices (diagnostic catheters, wound management, infusion sets, pressure cuffs, drug delivery cassettes and cartridges); laboratory diagnostics (lab blood diagnostics, mass spectometry, high pressure liquid chromatography, dialysis); imaging and monitoring (ultrasound, CT, MRI, PET, X-ray, patient monitoring); and patient mobility (hospital beds, patient mobility systems).
Flextronics Announces the Acquisition of RIWISA
On November 4, 2013, Flextronics announced that we have completed the acquisition of RIWISA AG. As a result of the transaction, we have acquired RIWISA's state-of-the-art manufacturing facilities located in Hägglingen, Switzerland, and highly experienced employees in medical, consumer packaging and industrial products. With the close of the acquisition, we broaden our precision injection molding and high-speed automation offerings.
Visit the RIWISA website >>